myelodysplastic syndromes (MDS) | Page 102 | Aplastic Anemia and MDS International Foundation

myelodysplastic syndromes (MDS)

Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: a retrospective study of 322 bone marrows.

Author(s): 
Buckstein R, Jang K, Friedlich J, Zhang L, Reis M, Chesney A, Wells RA.
Primary Author: 
Buckstein R
Journal Title: 
Leuk Res
Original Publication Date: 
Mar 2009

Although unexplained anemia is common in the elderly, the prevalence of MDS is poorly defined. We reviewed 2267 bone marrows reviewed at our

Bone Marrow Diseases: 

Neighborhood socioeconomic status influences the survival of elderly patients with myelodysplastic syndromes in the United States.

Author(s): 
Wang R, Gross CP, Halene S, Ma X
Primary Author: 
Wang R
Journal Title: 
Cancer Causes Control
Original Publication Date: 
May 2009

The potential role of socioeconomic status (SES) in the survival of

Bone Marrow Diseases: 

Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial.

Author(s): 
Steensma DP, Baer MR, Slack JL, Buckstein R, Godley LA, Garcia-Manero G, Albitar M, Larsen JS, Arora S, Cullen MT, Kantarjian H
Primary Author: 
Steensma DP
Journal Title: 
J Clin Oncol
Original Publication Date: 
Jun 2009

PURPOSE:

Bone Marrow Diseases: